Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Roflumilast

Filters
×

filter

ROFLUMILAST

filter

5712298

8431154

8536206

8604064

8618142

9468598

filter

Y

Blank

filter

Y

Blank

filter

2020-01-27

2023-02-19

2024-03-08

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

5712298

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2020-01-27

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8618142

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-03-08

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8604064

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-03-08

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8618142

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2024-03-08

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8536206

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-03-08

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9468598

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2023-02-19

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

5712298

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2020-01-27

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8536206

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-03-08

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

9468598

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2023-02-19

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8604064

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-03-08

Patent Use Code

U-1115

Delist Requested

Application Number

22522

Patent Use Description

TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8431154

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2023-02-19

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8431154

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2023-02-19

Patent Use Code

Delist Requested

Application Number

22522

Patent Use Description

Product Number

2

PharmaCompass >>

First
Previous
Next
Last